FSHD

Clinical trials for FSHD explained in plain language.

Never miss a new study

Get alerted when new FSHD trials appear

Sign up with your email to follow new studies for FSHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New drug trial aims to protect muscle in rare genetic disease

Disease control Not yet recruiting

This study is testing whether an investigational drug called apitegromab can help preserve muscle in adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. About 60 participants will receive either the drug or a pla…

Matched conditions: FSHD

Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control

Last updated Apr 02, 2026 04:57 UTC

FSHD

Get alerted when new FSHD trials appear

New drug trial aims to protect muscle in rare genetic disease